Evidence map›Paper›PMID 14638516›Full record

ArticleAntimicrobial agents and chemotherapy2003

Efficacy of sulforaphane in eradicating Helicobacter pylori in human gastric xenografts implanted in nude mice.

Xavier Haristoy, Karine Angioi-Duprez, Adrien Duprez, Alain Lozniewski

Open access · greenAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 1 synthesis or guideline pooled it, 84 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Beyond Antibiotics: Alternative Strategies TargetingExpert reviews in molecular medicine · 2026
    Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Chebulinic acid isolated from aqueous extracts ofFrontiers in microbiology · 2024
    Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. In Silico and In Vitro Analysis of Sulforaphane Anti-Antibiotics (Basel, Switzerland) · 2022
    Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Xavier HaristoyLaboratoire de Bactériologie-Virologie, UMR CNRS 75-65, Faculté de Médecine, Université Henri-Poincaré, Vandaeuvre-les-Nancy, France.
Karine Angioi-Duprez
Adrien Duprez
Alain Lozniewski
Institut de Virologie · FRInserm · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sulforaphane, an isothiocyanate abundant in the form of its glucosinolate precursor in broccoli sprouts, has shown in vitro activity against Helicobacter pylori. We evaluated the effect of sulforaphane in vivo against this bacterium by using human gastric xenografts in nude mice. H. pylori was completely eradicated in 8 of the 11 sulforaphane-treated grafts. This result suggests that sulforaphane might be beneficial in the treatment of H. pylori-infected individuals.

Indexed as

Helicobacter pyloriTransplantation, HeterologousAnimalsAnti-Infective AgentsBrassicaColony Count, MicrobialHelicobacter InfectionsHumansIsothiocyanatesMiceMice, NudePlant ExtractsStomachSulfoxidesThiocyanatesAnti-Infective AgentsIsothiocyanatesPlant ExtractssulforaphaneSulfoxidesThiocyanates

Identifiers

PMID14638516
PMCPMC296232
OpenAlexW1989763105

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.